| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7b7f213a73890f7392ba1604165d9484 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-50 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70596
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2896
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-80 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 |
| filingDate |
2018-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bcdb38721e72f4b338738e8ff84dbe0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fc1e282d5ce94fdfa6538881764cc04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dcb9f9888c0018474ba65307af03e2ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db3269fa654200ce93b72527dac33e73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66879a22f084d2717aef62bc6dfcee01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0362f020274621063b18a5809376ea1 |
| publicationDate |
2019-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201910349-A |
| titleOfInvention |
Compositions, methods and/or kits comprising a recombinant human CD38 extracellular region |
| abstract |
Compositions that bind to anti-CD38 antibodies include specific sequences of recombinant soluble forms of the extracellular region of CD38 and / or fragments thereof that interfere with the aforementioned anti-CD38 antibody-binding activity. The foregoing compositions may be included in a kit for biological surveillance research and diagnostic analysis. The foregoing compositions can be used to neutralize anti-CD38 antibodies in a sample and / or select suitable red blood cell units for use in patients treated with anti-CD38 antibodies. |
| priorityDate |
2017-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |